Organization
Thermo Fisher was rated High Risk because it has adopted identity-based hiring and philanthropic practices that prioritize group characteristics over merit, and because its corporate governance shows strong alignment with partisan advocacy and political spending. These combined governance and policy choices suggest the company has moved away from neutral business priorities toward divisive political engagement.
Thermo Fisher Scientific Inc. is an American life science and clinical research company. It is a global supplier of analytical instruments, clinical development solutions, specialty diagnostics, laboratory, pharmaceutical and biotechnology services. Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021).
